Covid-19 Impact on Neuroprotective Products Market, Global Research Reports 2020-2021

June 2020 | 97 pages | ID: CD21381DA8B7EN
QYResearch

Abstracts

This report covers market size and forecasts of Neuroprotective Products, including the following market information:

• Global Neuroprotective Products Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
• Global Neuroprotective Products Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
• Global Neuroprotective Products Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
• Global Neuroprotective Products Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)

Key market players

Major competitors identified in this market include Genervon Biopharmaceuticals (Canada), NeuroVive Pharmaceutical (Sweden), Ceregene (USA), BHRPharma (Thailand), Neuren Pharmaceuticals (Australia), Allon therapeutics (Canada), Bionure Inc. (USA), etc.

Based on the Region:

• Asia-Pacific (China, Japan, South Korea, India and ASEAN)
• North America (US and Canada)
• Europe (Germany, France, UK and Italy)
• Rest of World (Latin America, Middle East & Africa)

Based on the Type:

• Cholinesterase inhibitors
• NMDA receptor antagonists
• Others

Based on the Application:

• Alzheimer's disease
• Multiple sclerosis
• Others

Contents

1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
  1.4.1 Research Process
  1.4.2 Data Triangulation
  1.4.3 Research Approach
  1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.5.2 Covid-19 Impact: Commodity Prices Indices
  1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Neuroprotective Products Industry
1.7 COVID-19 Impact: Neuroprotective Products Market Trends

2 GLOBAL NEUROPROTECTIVE PRODUCTS QUARTERLY MARKET SIZE ANALYSIS

2.1 Neuroprotective Products Business Impact Assessment - COVID-19
  2.1.1 Global Neuroprotective Products Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  2.1.2 Global Neuroprotective Products Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Neuroprotective Products Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  2.3.1 Drivers
  2.3.2 Restraints
  2.3.3 Opportunities
  2.3.4 Challenges

3 QUARTERLY COMPETITIVE ASSESSMENT, 2020

3.1 Global Neuroprotective Products Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Neuroprotective Products Factory Price by Manufacturers
3.3 Location of Key Manufacturers Neuroprotective Products Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Neuroprotective Products Market
3.5 Key Manufacturers Neuroprotective Products Product Offered
3.6 Mergers & Acquisitions, Expansion Plans

4 IMPACT OF COVID-19 ON NEUROPROTECTIVE PRODUCTS SEGMENTS, BY TYPE

4.1 Introduction
  1.4.1 Cholinesterase inhibitors
  1.4.2 NMDA receptor antagonists
  1.4.3 Others
4.2 By Type, Global Neuroprotective Products Market Size, 2019-2021
  4.2.1 By Type, Global Neuroprotective Products Market Size by Type, 2020-2021
  4.2.2 By Type, Global Neuroprotective Products Price, 2020-2021

5 IMPACT OF COVID-19 ON NEUROPROTECTIVE PRODUCTS SEGMENTS, BY APPLICATION

5.1 Overview
  5.5.1 Alzheimer's disease
  5.5.2 Multiple sclerosis
  5.5.3 Others
5.2 By Application, Global Neuroprotective Products Market Size, 2019-2021
  5.2.1 By Application, Global Neuroprotective Products Market Size by Application, 2019-2021
  5.2.2 By Application, Global Neuroprotective Products Price, 2020-2021

6 GEOGRAPHIC ANALYSIS

6.1 Introduction
6.2 North America
  6.2.1 Macroeconomic Indicators of US
  6.2.2 US
  6.2.3 Canada
6.3 Europe
  6.3.1 Macroeconomic Indicators of Europe
  6.3.2 Germany
  6.3.3 France
  6.3.4 UK
  6.3.5 Italy
6.4 Asia-Pacific
  6.4.1 Macroeconomic Indicators of Asia-Pacific
  6.4.2 China
  6.4.3 Japan
  6.4.4 South Korea
  6.4.5 India
  6.4.6 ASEAN
6.5 Rest of World
  6.5.1 Latin America
  6.5.2 Middle East and Africa

7 COMPANY PROFILES

7.1 Genervon Biopharmaceuticals (Canada)
  7.1.1 Genervon Biopharmaceuticals (Canada) Business Overview
  7.1.2 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Quarterly Production and Revenue, 2020
  7.1.3 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Product Introduction
  7.1.4 Genervon Biopharmaceuticals (Canada) Response to COVID-19 and Related Developments
7.2 NeuroVive Pharmaceutical (Sweden)
  7.2.1 NeuroVive Pharmaceutical (Sweden) Business Overview
  7.2.2 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Quarterly Production and Revenue, 2020
  7.2.3 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Product Introduction
  7.2.4 NeuroVive Pharmaceutical (Sweden) Response to COVID-19 and Related Developments
7.3 Ceregene (USA)
  7.3.1 Ceregene (USA) Business Overview
  7.3.2 Ceregene (USA) Neuroprotective Products Quarterly Production and Revenue, 2020
  7.3.3 Ceregene (USA) Neuroprotective Products Product Introduction
  7.3.4 Ceregene (USA) Response to COVID-19 and Related Developments
7.4 BHRPharma (Thailand)
  7.4.1 BHRPharma (Thailand) Business Overview
  7.4.2 BHRPharma (Thailand) Neuroprotective Products Quarterly Production and Revenue, 2020
  7.4.3 BHRPharma (Thailand) Neuroprotective Products Product Introduction
  7.4.4 BHRPharma (Thailand) Response to COVID-19 and Related Developments
7.5 Neuren Pharmaceuticals (Australia)
  7.5.1 Neuren Pharmaceuticals (Australia) Business Overview
  7.5.2 Neuren Pharmaceuticals (Australia) Neuroprotective Products Quarterly Production and Revenue, 2020
  7.5.3 Neuren Pharmaceuticals (Australia) Neuroprotective Products Product Introduction
  7.5.4 Neuren Pharmaceuticals (Australia) Response to COVID-19 and Related Developments
7.6 Allon therapeutics (Canada)
  7.6.1 Allon therapeutics (Canada) Business Overview
  7.6.2 Allon therapeutics (Canada) Neuroprotective Products Quarterly Production and Revenue, 2020
  7.6.3 Allon therapeutics (Canada) Neuroprotective Products Product Introduction
  7.6.4 Allon therapeutics (Canada) Response to COVID-19 and Related Developments
7.7 Bionure Inc. (USA)
  7.7.1 Bionure Inc. (USA) Business Overview
  7.7.2 Bionure Inc. (USA) Neuroprotective Products Quarterly Production and Revenue, 2020
  7.7.3 Bionure Inc. (USA) Neuroprotective Products Product Introduction
  7.7.4 Bionure Inc. (USA) Response to COVID-19 and Related Developments

8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS

8.1 Neuroprotective Products Supply Chain Analysis
  8.1.1 Neuroprotective Products Supply Chain Analysis
  8.1.2 Covid-19 Impact on Neuroprotective Products Supply Chain
8.2 Distribution Channels Analysis
  8.2.1 Neuroprotective Products Distribution Channels
  8.2.2 Covid-19 Impact on Neuroprotective Products Distribution Channels
  8.2.3 Neuroprotective Products Distributors
8.3 Neuroprotective Products Customers

9 KEY FINDINGS

10 APPENDIX

10.1 About Us
10.2 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Neuroprotective Products Assessment
Table 9. COVID-19 Impact: Neuroprotective Products Market Trends
Table 10. COVID-19 Impact Global Neuroprotective Products Market Size
Table 11. Global Neuroprotective Products Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (MT)
Table 12. Global Neuroprotective Products Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Kg)
Table 13. Global Neuroprotective Products Quarterly Market Size, 2020 (US$ Million) & (MT)
Table 14. Global Neuroprotective Products Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Neuroprotective Products Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (MT)
Table 16. Global Neuroprotective Products Market Growth Drivers
Table 17. Global Neuroprotective Products Market Restraints
Table 18. Global Neuroprotective Products Market Opportunities
Table 19. Global Neuroprotective Products Market Challenges
Table 20. Key Manufacturers Neuroprotective Products Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Neuroprotective Products Market Size, 2019 (MT) & (US$ Million)
Table 22. Neuroprotective Products Factory Price by Manufacturers 2020 (USD/Kg)
Table 23. Location of Key Manufacturers Neuroprotective Products Manufacturing Plants
Table 24. Key Manufacturers Neuroprotective Products Market Served
Table 25. Date of Key Manufacturers Enter into Neuroprotective Products Market
Table 26. Key Manufacturers Neuroprotective Products Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neuroprotective Products Market Size by Type, 2020, (US$ Million)
Table 29. Global Neuroprotective Products Market Size by Type, 2020 (MT)
Table 30. Global Neuroprotective Products Price: by Type, 2020-2021 (USD/Kg)
Table 31. Global Neuroprotective Products Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Neuroprotective Products Market Size by Application, 2020-2021 (MT)
Table 33. Global Neuroprotective Products Price: by Application, 2020-2021 (USD/Kg)
Table 34. Global Neuroprotective Products Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Neuroprotective Products Market Size by Region, 2019-2021 (MT)
Table 36. By Country, North America Neuroprotective Products Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Neuroprotective Products Market Size, 2019-2021 (MT)
Table 38. US Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 39. Canada Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Neuroprotective Products Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Neuroprotective Products Market Size, 2019-2021 (MT)
Table 43. Germany Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 44. France Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 45. UK Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 46. Italy Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Neuroprotective Products Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Neuroprotective Products Market Size, 2019-2021 (MT)
Table 50. China Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 51. Japan Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 52. South Korea Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 53. India Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 54. ASEAN Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 55. Latin America Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 56. Middle East and Africa Neuroprotective Products Market Size, 2019-2021 (US$ Million) & (MT)
Table 57. Genervon Biopharmaceuticals (Canada) Business Overview
Table 58. Genervon Biopharmaceuticals (Canada) Neuroprotective Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Genervon Biopharmaceuticals (Canada) Neuroprotective Products Product
Table 60. Genervon Biopharmaceuticals (Canada) Response to COVID-19 and Related Developments
Table 61. NeuroVive Pharmaceutical (Sweden) Business Overview
Table 62. NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Product
Table 64. NeuroVive Pharmaceutical (Sweden) Response to COVID-19 and Related Developments
Table 65. Ceregene (USA) Business Overview
Table 66. Ceregene (USA) Neuroprotective Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Ceregene (USA) Neuroprotective Products Product
Table 68. Ceregene (USA) Response to COVID-19 and Related Developments
Table 69. BHRPharma (Thailand) Business Overview
Table 70. BHRPharma (Thailand) Neuroprotective Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. BHRPharma (Thailand) Neuroprotective Products Product
Table 72. BHRPharma (Thailand) Response to COVID-19 and Related Developments
Table 73. Neuren Pharmaceuticals (Australia) Business Overview
Table 74. Neuren Pharmaceuticals (Australia) Neuroprotective Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Neuren Pharmaceuticals (Australia) Neuroprotective Products Product
Table 76. Neuren Pharmaceuticals (Australia) Response to COVID-19 and Related Developments
Table 77. Allon therapeutics (Canada) Business Overview
Table 78. Allon therapeutics (Canada) Neuroprotective Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Allon therapeutics (Canada) Neuroprotective Products Product
Table 80. Allon therapeutics (Canada) Response to COVID-19 and Related Developments
Table 81. Bionure Inc. (USA) Business Overview
Table 82. Bionure Inc. (USA) Neuroprotective Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Bionure Inc. (USA) Neuroprotective Products Product
Table 84. Bionure Inc. (USA) Response to COVID-19 and Related Developments
Table 85. Neuroprotective Products Distributors List
Table 86. Neuroprotective Products Customers List
Table 87. Covid-19 Impact on Neuroprotective Products Customers

List Of Figures

LIST OF FIGURES

Figure 1. Neuroprotective Products Product Picture
Figure 2. Neuroprotective Products Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Neuroprotective Products Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Neuroprotective Products Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Neuroprotective Products Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Neuroprotective Products Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Neuroprotective Products Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Neuroprotective Products Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Neuroprotective Products Market Size Market Share, 2019-2021